Passive Transfer of Animal-Derived Polyclonal Hyperimmune Antibodies Provides Protection of Mice from Lethal Lassa Virus Infection

Background: Lassa virus (LASV) can cause severe acute systemic infection in humans. No approved antiviral drugs or vaccines are currently available. Antibody-based therapeutics are considered a promising treatment strategy in the management of LASV disease. Methods: We used chimeric Ifnar<sup>−/−</s...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Lisa Oestereich, Helena Müller-Kräuter, Elisa Pallasch, Thomas Strecker
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	MDPI AG 2023-06-01
Edice:	Viruses
Témata:	Lassa mammarenavirus Lassa fever arenavirus virus-like particle neutralizing antibodies in vivo protection
On-line přístup:	https://www.mdpi.com/1999-4915/15/7/1436
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!